<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id><journal-id journal-id-type="pmc">eid</journal-id><journal-title>Emerging Infectious Diseases</journal-title><issn pub-type="ppub">1080-6040</issn><issn pub-type="epub">1080-6059</issn><publisher><publisher-name>Centers for Disease Control</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">10221877</article-id><article-id pub-id-type="pmc">2640698</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>emm typing and validation of provisional M types for group A streptococci.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Facklam</surname><given-names>R.</given-names></name><email>rrf2@cdc.gov</email></contrib><contrib contrib-type="author"><name><surname>Beall</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Efstratiou</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fischetti</surname><given-names>V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Johnson</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kaplan</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kriz</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lovgren</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Martin</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Schwartz</surname><given-names>B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Totolian</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bessen</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hollingshead</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rubin</surname><given-names>F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Scott</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tyrrell</surname><given-names>G.</given-names></name></contrib></contrib-group><aff>Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.</aff><pub-date pub-type="ppub"><season>Mar-Apr</season><year>1999</year></pub-date><volume>5</volume><issue>2</issue><fpage>247</fpage><lpage>253</lpage><abstract><p>This report discusses the following issues related to typing of group A streptococci (GAS): The development and use of the 5' emm variable region sequencing (emm typing) in relation to the existing serologic typing system; the designation of emm types in relation to M types; a system for validation of new emm types; criteria for validation of provisional M types to new M-types; a list of reference type cultures for each of the M-type or emm-type strains of GAS; the results of the first culture exchange program for a quality control testing system among the national and World Health Organization collaborating centers for streptococci; and dissemination of new approaches to typing of GAS to the international streptococcal community.</p></abstract></article-meta></front></article>